Strobeck Matthew's Form 4 filing
Biodesix Inc (BDSX) · filed Nov 21, 2022
- Accession no.
- 0001140361-22-042597
- Filed
- Nov 21, 2022
- Trade date
- Nov 21, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market purchases total $3.07M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Strobeck MatthewCIK 0001377832 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2022 | Common Stock | PPurchaseAcquired | +869,565 | $1.15 | +$999,999.75 | 2,415,151 | Direct | |
| Nov 21, 2022 | Common Stock | PPurchaseAcquired | +108,695 | $1.15 | +$124,999.25 | 112,213 | Indirect | |
| Nov 21, 2022 | Common Stock | PPurchaseAcquired | +108,695 | $1.15 | +$124,999.25 | 112,213 | Indirect | |
| Nov 21, 2022 | Common Stock | PPurchaseAcquired | +108,695 | $1.15 | +$124,999.25 | 112,213 | Indirect | |
| Nov 21, 2022 | Common Stock | PPurchaseAcquired | +108,695 | $1.15 | +$124,999.25 | 112,213 | Indirect | |
| Nov 21, 2022 | Common Stock | PPurchaseAcquired | +1,365,217 | $1.15 | +$1,569,999.55 | 2,135,076 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.